In a 35‑week gestation patient with preterm premature rupture of membranes (PPROM) who has completed a 12‑hour course of antenatal steroids and has been receiving intravenous cefazolin, should the antibiotic be switched to oral erythromycin and should labor be initiated with oxytocin (Pitocin)?

Management of 35-Week PPROM After 12 Hours of Steroids on IV Cefazolin

At 35 weeks gestation with completed steroids, you should proceed with delivery using oxytocin induction rather than continuing expectant management with antibiotics. 1

Antibiotic Management at 35 Weeks

The evidence for antibiotic benefit in PPROM is gestational-age dependent, with clear benefit demonstrated before 34 weeks but minimal to no benefit at or beyond 34-35 weeks 2, 1, 3.

• RCOG guidelines recommend erythromycin for 10 days or until established labor for PPROM from 24+0 weeks, but the strength of evidence diminishes significantly after 34 weeks 1
• SMFM guidelines specifically recommend antibiotics for PPROM at <34 weeks gestation 2
• The number needed to treat increases substantially at 34-35 weeks, making routine antibiotic continuation less justified 1

If Continuing Antibiotics (Not Recommended at 35 Weeks)

Should you choose expectant management despite the gestational age:

• Do NOT switch to oral erythromycin alone - cefazolin (IV cephalosporin) is not the standard regimen
• Standard regimens include:
  • Ampicillin + erythromycin IV for 48h, then amoxicillin + erythromycin PO for 5 days 2, 3
  • Erythromycin 250mg PO q6h for 10 days 1
  • Azithromycin can substitute for erythromycin 2, 4

Cefazolin monotherapy is not evidence-based for PPROM latency prolongation 5, 6

Oxytocin Induction at 35 Weeks

Yes, initiate oxytocin for delivery at 35 weeks. Here's why:

Timing Considerations

• At 35 weeks, the fetus has completed the critical window where steroid benefit is maximal (24-34 weeks) 1
• Steroids at 34-35 weeks should be "considered" rather than routinely offered, given the high number needed to treat and potential side effects 1
• The risks of expectant management (chorioamnionitis, cord prolapse, abruption) increasingly outweigh benefits of latency prolongation beyond 34 weeks

Oxytocin Safety Requirements

Per FDA labeling, oxytocin administration requires 7:

• Hospital setting with continuous trained observation
• Immediately available physician qualified to manage complications
• Electronic fetal monitoring (preferably with intrauterine pressure catheter for accurate contraction assessment)
• Careful patient selection excluding fetal distress, prematurity concerns (not applicable at 35 weeks), and conditions predisposing to uterine rupture

Contraindications to Check

Before oxytocin, ensure absence of 7:

• Fetal distress
• Abnormal fetal presentation
• Cephalopelvic disproportion
• Previous major uterine surgery (relative contraindication requiring careful assessment)
• Signs of chorioamnionitis requiring immediate delivery

Clinical Algorithm

For 35-week PPROM with completed steroids:

1. Confirm gestational age - if truly 35+0 weeks or beyond, proceed to delivery
2. Assess for contraindications to labor induction (see above)
3. Discontinue cefazolin - not indicated for latency prolongation at this gestational age
4. Begin oxytocin induction with appropriate monitoring 7
5. Administer GBS prophylaxis if indicated (separate from latency antibiotics) 3

If between 34+0-34+6 weeks:

• Steroids may be considered on individual basis 1
• Expectant management with appropriate antibiotics (ampicillin + erythromycin regimen) remains reasonable
• Delivery planning should be individualized but generally favored by 35 weeks

Key Pitfalls to Avoid

• Don't continue expectant management indefinitely at 35 weeks - the risk-benefit ratio shifts toward delivery
• Don't use cefazolin monotherapy for PPROM - it lacks evidence for latency prolongation
• Don't forget GBS prophylaxis during labor if indicated - this is separate from latency antibiotics 3
• Don't use amoxicillin-clavulanate - associated with increased necrotizing enterocolitis risk 2, 1, 3